260 related articles for article (PubMed ID: 8313401)
21. A double-blind comparative study of brofaromine and fluvoxamine in outpatients with panic disorder.
van Vliet IM; den Boer JA; Westenberg HG; Slaap BR
J Clin Psychopharmacol; 1996 Aug; 16(4):299-306. PubMed ID: 8835705
[TBL] [Abstract][Full Text] [Related]
22. [Monoamine oxidase inhibitors in psychiatry. Status of current knowledge].
Volz HP; Gleiter CH; Möller HJ
Nervenarzt; 1996 May; 67(5):339-47. PubMed ID: 9005342
[TBL] [Abstract][Full Text] [Related]
23. Reversible and selective inhibitors of monoamine oxidase A in mental and other disorders.
Priest RG; Gimbrett R; Roberts M; Steinert J
Acta Psychiatr Scand Suppl; 1995; 386():40-3. PubMed ID: 7717094
[TBL] [Abstract][Full Text] [Related]
24. Reversible monoamine oxidase-A inhibitors in social phobia.
Liebowitz MR; Schneier F; Gitow A; Feerick J
Clin Neuropharmacol; 1993; 16 Suppl 2():S83-8. PubMed ID: 8313403
[TBL] [Abstract][Full Text] [Related]
25. Meta-analysis of the reversible inhibitors of monoamine oxidase type A moclobemide and brofaromine for the treatment of depression.
Lotufo-Neto F; Trivedi M; Thase ME
Neuropsychopharmacology; 1999 Mar; 20(3):226-47. PubMed ID: 10063483
[TBL] [Abstract][Full Text] [Related]
26. Clomipramine in the treatment of agoraphobic inpatients resistant to behavioral therapy.
Hoffart A; Due-Madsen J; Lande B; Gude T; Bille H; Torgersen S
J Clin Psychiatry; 1993 Dec; 54(12):481-7. PubMed ID: 8276739
[TBL] [Abstract][Full Text] [Related]
27. Differential response patterns to MAO inhibitors and tricyclics.
Nies A
J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):70-7. PubMed ID: 6376487
[TBL] [Abstract][Full Text] [Related]
28. Alprazolam premedication and 35% carbon dioxide vulnerability in panic patients.
Pols H; Verburg K; Hauzer R; Meijer J; Griez E
Biol Psychiatry; 1996 Nov; 40(9):913-7. PubMed ID: 8896779
[TBL] [Abstract][Full Text] [Related]
29. Treatment of panic disorder.
Cassano GB; Toni C; Musetti L
Adv Biochem Psychopharmacol; 1992; 47():449-60. PubMed ID: 1509926
[No Abstract] [Full Text] [Related]
30. Clinical pharmacology of reversible monoamine oxidase-A inhibitors.
Bieck PR; Antonin KH; Schmidt E
Clin Neuropharmacol; 1993; 16 Suppl 2():S34-41. PubMed ID: 8313395
[TBL] [Abstract][Full Text] [Related]
31. Psychopharmacological treatment of panic disorder.
Bowden CL
Bull Menninger Clin; 1992; 56(2 Suppl A):A29-41. PubMed ID: 1623338
[TBL] [Abstract][Full Text] [Related]
32. Medication treatments for panic disorder and social phobia.
Stein MB
Depress Anxiety; 1998; 7(3):134-8. PubMed ID: 9656095
[TBL] [Abstract][Full Text] [Related]
33. Moclobemide versus clomipramine in the treatment of depression: a double-blind multicentre study in Belgium.
Dierick M; Cattiez P; Franck G; Burton P; Defleur J; Hermans W; Roelandts A; Wolfrum C; Berger M; Hellstern K
Acta Psychiatr Scand Suppl; 1990; 360():50-1. PubMed ID: 2248071
[TBL] [Abstract][Full Text] [Related]
34. Brofaromine--a selective, reversible, and short-acting MAO-A inhibitor: review of the pharmacological and clinical findings.
Möller HJ; Wendt G; Waldmeier P
Pharmacopsychiatry; 1991 Mar; 24(2):50-4. PubMed ID: 1852792
[TBL] [Abstract][Full Text] [Related]
35. The Galway Study of Panic Disorder. I: Clomipramine and lofepramine in DSM III-R panic disorder: a placebo controlled trial.
Fahy TJ; O'Rourke D; Brophy J; Schazmann W; Sciascia S
J Affect Disord; 1992 May; 25(1):63-75. PubMed ID: 1624646
[TBL] [Abstract][Full Text] [Related]
36. [Indications for therapy using MAO inhibitors].
Schmauss M; Erfurth A
Psychiatr Prax; 1989 Aug; 16 Suppl 1():2-6. PubMed ID: 2685853
[TBL] [Abstract][Full Text] [Related]
37. Panic attacks. A review of treatments and pathogenesis.
Grunhaus L; Gloger S; Weisstub E
J Nerv Ment Dis; 1981 Oct; 169(10):608-13. PubMed ID: 6116741
[TBL] [Abstract][Full Text] [Related]
38. An open trial of fluvoxamine therapy for panic disorder complicated by depression.
Spiegel DA; Saeed SA; Bruce TJ
J Clin Psychiatry; 1996; 57 Suppl 8():37-40; discussion 40-1. PubMed ID: 8698679
[TBL] [Abstract][Full Text] [Related]
39. Clomipramine treatment of panic disorder: pros and cons.
Papp LA; Schneier FR; Fyer AJ; Leibowitz MR; Gorman JM; Coplan JD; Campeas R; Fallon BA; Klein DF
J Clin Psychiatry; 1997 Oct; 58(10):423-5. PubMed ID: 9375591
[TBL] [Abstract][Full Text] [Related]
40. Moclobemide for anxiety disorders: a focus on moclobemide for panic disorder.
Tiller JW; Bouwer C; Behnke K
Int Clin Psychopharmacol; 1997 Oct; 12 Suppl 6():S27-30. PubMed ID: 9466172
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
